drugset / Trial / NCT05958758
A Community of Practice Program With Psilocybin-assisted Therapy for End-of-Life Patients
Phase 0
Unknown
64 enrolled
The Roots to Thrive Society for Psychedelic Therapy
Vancouver Island Health Authority · collabVancouver Island University · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to understand the feasibility of a resilience focused community of practice program that includes psilocybin-assisted therapy for End-of-Life Distress. The community of practice refers to a research informed group therapy process that runs over a 10-week period of time and includes one group administered psilocybin-assisted therapy session. Target population: The treatment team will treat a total of 64 patients who have: * a terminal diagnosis (experiencing end of life distress), * AND who are eligible for the RTT + Psilocybin-assisted Therapy Treatment program through the RTT Society.
Timeline
- Start
- 2023-09-01
- Primary completion
- 2025-04-30
- Completion
- 2025-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | — | — |
| Subject | Psilocybin-assisted therapy within a community of practice model (group administered) | Unknown | — | — |
Indications
No indication recorded.